dsm-firmenich repurchases 152,262 shares in latest week of buyback program

Corporate Action
โดย GlobeNewswire·Read original
Summary · why it matters

dsm-firmenich repurchased 152,262 ordinary shares during the week of July 20 through July 24, 2026, at an average price of €83.61 per share for a total of €12.7 million. The buyback is part of a larger program announced on February 9, 2026, which includes a €40 million tranche to cover share-based compensation plans—already completed on March 23, 2026—and a €500 million tranche to reduce issued capital, expected to finish by the end of the third quarter of 2026. To date, the company has bought back 4,972,593 shares under the overall program at an average price of €67.53, totaling €335.8 million.

Impact on stocks 1

Synthetic Biology (non-pharma) · 1 stocks
DSM-Firmenich AG
DSFIR
▲ PositiveCapitalrelevance

Company repurchased shares as part of a buyback program to reduce issued capital, signaling confidence and returning value to shareholders.